Palladium-Catalyzed Borylation of Aryl Chlorides: Scope, Applications, and Computational Studies

From chloride to boronate: Catalysts comprising palladium and biaryl monophosphine ligands provide highly active systems for the borylation of aryl and heteroaryl chlorides (see scheme). Symmetrical and unsymmetrical biaryl products can also be prepared directly from two aryl chlorides without isola...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie (International ed.) Vol. 46; no. 28; pp. 5359 - 5363
Main Authors Billingsley, Kelvin L, Barder, Timothy E, Buchwald, Stephen L
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 01.01.2007
WILEY-VCH Verlag
WILEY‐VCH Verlag
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:From chloride to boronate: Catalysts comprising palladium and biaryl monophosphine ligands provide highly active systems for the borylation of aryl and heteroaryl chlorides (see scheme). Symmetrical and unsymmetrical biaryl products can also be prepared directly from two aryl chlorides without isolation of the intermediate boronate esters. Computational studies provide insight into the roles of the biaryl phosphine ligand and the KOAc base in the catalytic cycle.
Bibliography:http://dx.doi.org/10.1002/anie.200701551
ark:/67375/WNG-BRC0PH60-B
National Institutes of Health - No. GM 46059
NSF - No. CHE 9808061; No. DBI 9729592
Amgen
Boehringer Ingelheim
We thank the National Institutes of Health (GM 46059) for support of this work. We are grateful to Merck, Amgen, Boehringer Ingelheim, BASF (Pd(OAc)2), and Saltigo (XPhos) for additional support. The Varian NMR instruments used in this work were purchased with funding from the NSF (CHE 9808061 and DBI 9729592).
istex:174713C225F61D6F2BBC271B1CF4F07F144FCCD3
Merck
ArticleID:ANIE200701551
and Saltigo (XPhos) for additional support. The Varian NMR instruments used in this work were purchased with funding from the NSF (CHE 9808061 and DBI 9729592).
2
We thank the National Institutes of Health (GM 46059) for support of this work. We are grateful to Merck, Amgen, Boehringer Ingelheim, BASF (Pd(OAc)
Medline
NIH RePORTER
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.200701551